retatrutide trial status produces up to 30.3% weight loss in Phase 3 Retatrutide, an investigational triple hormone

Explore Retatrutide UK, a triple receptor agonist research peptide investigated for its interaction with GLP-1, GIP and glucagon metabolic signalling pathways.

With food lists, meals ideas & compare to GLP-1 medications like Ozempic

Diabetic medical spend dropped 0.5% while non-diabetic spend surged 17%

As a classic satiation signal, however, the literature illustrates a mixed picture of GIP involvement with an at best weak ...

I am Celiac, have had my gallbladder removed, and have lived most of my life with Acid Reflux and IBS

At TMC, we believe that effective weight management is about much more than a number on the scales